ASPR Adsouth Partners Inc (PK)

(Investrend Research Syndicate) AdSouth Partners (OTCBB: ASPR), with products in some 14,000 retail outlets including CVS (NYSE: CVS), Wal-Mart (NYSE: WMT), Linens'n Things (NYSE: LIN), and BJ's Wholesale Club, has been rated "Buy/5" in a Criterion report by Investrend Research analyst Gary Vassalotti. The analyst stated that the company: "Achieved large gains in the latest quarter in both EPS and Sales; "Intends to acquire, market and sell more products in addition to expanding its advertising revenues. The addition of products to the sales mix will tend to even out revenues and make earnings more predictable for investors; "Is positioned to leverage a new 23,000 sq foot facility, which allows complete in-house fulfillment and product modification via in-house packaging and assembly. The new in-house production capability could offer a new revenue stream; "Completed a financial restructuring in mid 2005, significantly improving its financial position; and "Has advertising sales concentrated with a few large customers." The analyst also noted the company operates in two segments, advertising and products. The advertising segment ($2.92m 2004 sales) provides placement of advertisements in television, internet, and print media. The product segment ($1.119m 2004 sales) has obtained the rights to sell various products, including Dermafresh, Simons Cosmetics, Hercules Hook, Pearl and E70 skin care products, greatly expanded from 2004 when ASPR only sold Dermafresh products. Combining both segments results in consolidated operating income of $837,000 (3rd qtr 2005) vs. $123,000 (3rd qtr 2004), a 580% increase. Net income rose to $816,000 (3rd qtr 2005) vs. $107,000 (3rd qtr 2004). Net results for the nine months, after charges for a $536,000 loss on extinguishing convertible notes was ($415,000) vs. a net loss of ($3.5mm) for the nine months of 2004. Adsouth's recent private placement provided $2.6 million in funds. An InvestorPower(TM) page has been created regarding the company at http://www.investrend.com/company/list.asp?sPathParam=yes. Investrend Research has been the leading independent equity research publishing and distribution program since 1996, with over 75 qualified professional analysts posting more than 1,000 reports to date. Anyone may enroll a company in the Investrend platforms. Enrollment fees for the Criterion research platform are $14,800, which is being paid by the company. Analysts are paid in advance for their initial reports by Investrend Research to limit or eliminate pecuniary interests, and no one associated with the program may own or trade in the equities of companies under coverage. The company has also been enrolled in the shareholder-monitoring program by the Shareholders Research Alliance (http://www.shareholdersresearch.com), established to eliminate conflict and bias, and Investrend subscribes to the exacting "Standards for Independent Research Providers" at http://www.firstresearchconsortium.com Anyone interested in receiving alerts regarding AdSouth research or webcasts should e-mail contact@investrend.com with "ASPR" in the subject line, or click on http://www.investrend.com/contact.asp.